Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: Lessons from the bedside for the benchside

Clinical and Experimental Rheumatology

Volumn 27, Issue 2 SUPPL.53, 2009, Pages

  Ozen, Seza ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Familial Mediterranean fever; Gene association; Vasculitis

Indexed keywords

C REACTIVE PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

3' UNTRANSLATED REGION; ANAPHYLACTOID PURPURA; ARTICLE; BEHCET DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ERYTHROCYTE SEDIMENTATION RATE; ETHNIC DIFFERENCE; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; NONHUMAN; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CYTOSKELETAL PROTEINS; HUMANS; IMMUNITY, INNATE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RHEUMATIC DISEASES; UP-REGULATION; VASCULITIS;

EID: 70350154328     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. PLENGE RM, PADYUKOV L, REMMERS EF et al.: Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044-1060
2. PHELAN JD, THOMPSON SD, GLASS DN: Susceptibility to JRA/JIA: complementing general autoimmune and arthritis traits. Genes Immun 2006; 7: 1-10.
3. BÁRTFAİ Z, GAEDE KI, RUSSELL KA et al.: Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin Immunol 2003; 109: 330-337
4. PLENGE RM, SElELSTAD M, PADYUKOV L et al.: TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007; 357: 1199-1209 (Pubitemid 47443179)
5. KARLSON EW, CHIBNIK LB, CUI J et al.: Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann Rheum Dis 2008; 67: 358-363
6. LEE YH, RHO YH, CHOI SJ et a.l: The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology (Oxford) 2007; 46: 49-56.
7. IKARI K, MOMOHARA S, INOUE E et al.: Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology (Oxford) 2006; 45: 1345-1348 (Pubitemid 44605467)
8. NOSE M: A proposal concept of a polygene network in systemic vasculitis: lessons from MRL mouse models. Allergol Int 2007; 56: 79-86.
9. CENTOLA M, AKSENTIJEVICH I, KASTNER DL: The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 1998; 7: 1581-1588
10. SAMUELS J, OZEN S: Familial Mediterranean fever and the other autoinflammatory Syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 2006; 18: 108-117
11. CHAE JJ, WOOD G, RICHARD K et al.: The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 2008; 112: 1794-1803
12. LACHMANN HJ, SENGÜL B, YAVUZŞEN TU et al.: Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-50.
13. OZEN S, BAKKALOGLU A, YILMAZ E et al.: Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 2003; 30: 2014-2018
14. KALYONCU M, ACAR BC, CAKAR N et al.: Are carriers for MEFV mutations "healthy"? Clin Exp Rheumatol 2006; 24 (Suppl. 42): S120-2.
15. OZEN S, BEN-CHETRIT E, BAKKALOGLU A et al.: Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 2001; 30: 281-287
16. TOUITOU I, MAGNE X, MOLINARI N et al.: MEFV mutations in Behçet's disease. Hum Mutat 2000; 16: 271-272
17. LIVNEH A, AKSENTIJEVICH I, LANGEVlTZ P et al.: A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease. Eur J Hum Genet 2001; 9: 191-196
18. TUNCA M, AKAR S, ONEN F et al. and THE TURKISH FMF STUDY GROUP: Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005; 84: 1-11.
19. RABINOVICH E, LIVNEH A, LANGEVITZ P et al.: Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 2005; 64: 1009-1014
20. LANGEVlTZ P, LIVNEH A, ZEMER D, SHEMER J, PRAS M: Seronegative spondylo-arthropathy in familial Mediterranean fever. Semin Arthritis Rheum 1997; 27: 67-72. (Pubitemid 27461152)
21. GERSHONI-BARUCH R, BROZA Y, BRIK R: Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr 2003; 143: 658-661 (Pubitemid 37452797)
22. YALÇINKAYA F, OZCAKAR ZB, KASAPÇOPUR O et al.: Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 2001; 151: 675-678
23. YlLMAZ E, OZEN S, BALCI B et al.: Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9: 553-555
24. TOMlYAMA N, HIGASHIUESATO Y, ODA T et al.: MEFV mutation analysis of familial Mediterranean fever in Japan. Clin Exp Rheumatol 2008; 26: 13-17
25. OZEN S, BESBAS N, BAKKALOGLU A, YILMAZ E: Pyrin Q148 mutation and familial Mediterranean fever. QJM 2002; 95: 32-33
26. BOOTH DR, LACHMANN HJ, GILLMORE JD, BOOTH SE, HAWKINS PN: Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. QJM 2001; 94: 527-531
27. USTEK D, EKMEKÇI C, OKU B et al.: MEFV gene 3′-UTR Alu repeat polymorphisms in patients with FMF. Clin Exp Rheumatol 2008; 26 (Suppl. 50): S72-6.
28. DAY TG, RAMANAN AV, HINKS A et al.: Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 2142-2146
29. AYAZ NA, OZEN S, BILGlNER Y et al.: MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 200); 48: 23-25 [Epub 2008 Nov 4]
30. OZEN S, HOFFMAN HM, FRENKEL J, KASTNER D: FMF and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA, 6-10 November 2005. Ann Rheum Dis 2006; 65: 961-964
31. MCGONAGLE D, MCDERMOTT MF: A proposed classification of the immunological diseases. PLoS Med 2006; 3: e297.